The Anti-Obesity Medications Market comprises prescription and (where allowed) over-the-counter pharmacotherapies developed to treat overweight and obesity by reducing appetite, increasing satiety, altering nutrient absorption, or modulating metabolic pathways. The market spans established drug classes (e.g., sibutramine-era agents, orlistat), modern incretin-based therapies (GLP-1 an... https://www.metatechinsights.com/industry-insights/anti-obesity-medications-market-2447